Zobrazeno 1 - 10
of 52
pro vyhledávání: '"P M Sandset"'
Autor:
L. Garabet, A. Eriksson, E. Tjønnfjord, M. Kringstad Olsen, H. K. Jacobsen, C. Tøvik Jørgensen, Å.-B. Mathisen, M.-C. Mowinckel, M. T. Ahlen, I. Hausberg Sørvoll, K. Daae Horvei, S. Leiknes Ernstsen, I. Jenssen Lægreid, P. M. Sandset, W. Ghanima
Publikováno v:
HemaSphere, Vol 6, Pp 1565-1566 (2022)
Externí odkaz:
https://doaj.org/article/979a026707214dda941c89b138bf1e09
Autor:
M, Olsson, T M, Stanne, A, Pedersen, E, Lorentzen, E, Kara, A, Martinez-Palacian, N P, Rønnow Sand, A F, Jacobsen, P M, Sandset, J J, Sidelmann, G, Engström, O, Melander, S M, Kanse, C, Jern
Publikováno v:
Journal of thrombosis and haemostasis : JTH. 16(10)
Essentials Knowledge of genetic regulators of plasma factor VII activating protease (FSAP) levels is limited. We performed a genome-wide analysis of variants influencing FSAP activity in Scandinavian cohorts. We replicated an association for Marburg-
Publikováno v:
Blood Coagulation & Fibrinolysis. 5:755-760
The effect of recombinant tissue factor pathway inhibitor (rTFPI) on extracellular matrix procoagulant activity was studied in a human ex vivo model of thrombogenesis. Extracellular matrix of endotoxin stimulated endothelial cells perfused with human
D-dimer levels and stroke progression in patients with acute ischemic stroke and atrial fibrillation
Publikováno v:
Acta neurologica Scandinavica. 124(1)
Patients with acute ischemic stroke and atrial fibrillation are at increased risk of stroke progression and recurrence. We sought to assess whether D-dimer and other markers of hemostatic activation could predict these adverse events in such patients
Publikováno v:
Journal of thrombosis and haemostasis : JTH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2314cdc626d4cc4eebb8ed552a03ae7
http://hdl.handle.net/11250/2377756
http://hdl.handle.net/11250/2377756
Publikováno v:
British journal of haematology. 115(2)
Recent studies suggest that low-dose oral contraceptives may cause acquired resistance to activated protein C (APC). The aims of this study were to determine whether hormone replacement therapy (HRT) may also induce acquired APC resistance and to stu
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 120(20)
Publikováno v:
Thrombosis and haemostasis. 85(5)
In a recent randomized, double-blind, placebo-controlled trial of women with a history of venous thromboembolism (VTE), we found that hormone replacement therapy (HRT) was associated with an early excess risk of recurrent thrombosis. The aims of the
Publikováno v:
Acta radiologica (Stockholm, Sweden : 1987). 42(3)
Strokes in patients with atrial fibrillation are often due to large middle cerebral artery (MCA) infarctions, caused by cardiogenic emboli. The purpose of this study was to characterise the large MCA infarctions and to describe the prevalence and pro
Publikováno v:
Thrombosis and haemostasis. 84(6)
Recent observational studies suggest a 2-4 fold increased risk of venous thromboembolism (VTE) in women taking hormone replacement therapy (HRT). The present study was started before publication of these studies, and the aim was to determine if HRT a